Bevacizumab maintenance treatment duration
Jun 05, 2023
Source: Cainiu Health
Dr. Qi Zhirong
Introduction
The maintenance treatment duration with bevacizumab is generally 2 to 3 weeks. Patients are advised to use the medication under the guidance of a physician and avoid self-administration to prevent adverse reactions and serious consequences. It is also important to maintain a balanced diet, including nutrient-rich foods such as eggs, milk, and fish. If any discomfort occurs, patients should seek medical attention promptly for evaluation.
Bevacizumab maintenance therapy is generally administered every 2 to 3 weeks. The detailed analysis is as follows:
Bevacizumab is an anti-tumor drug that inhibits vascular endothelial growth factor (VEGF), thereby suppressing the proliferation of tumor neovascular cells and reducing vascular permeability, achieving an anti-tumor effect. This drug is indicated for metastatic colorectal cancer, advanced, metastatic, or recurrent non-small cell lung cancer, and recurrent glioblastoma. For patients with recurrent glioblastoma, bevacizumab is typically administered once every two weeks; for other conditions, it is usually given once every three weeks. Therefore, the effective dosing interval of bevacizumab is generally 2–3 weeks.
Patients should use this medication under the guidance of a physician and avoid self-administration to prevent adverse effects and serious complications. It is also important to maintain a balanced diet, including nutrient-rich foods such as eggs, milk, and fish. If any discomfort occurs, patients should seek medical attention promptly for evaluation and timely treatment to avoid disease progression.
